Showing 1 - 10 of 2,258
. Here we explore the importance within the biotechnology industry of the non-financial metrics firms used to convey value … was a change over time in the importance of various metrics in determining the value of a biotechnology firm. We find that … value. Our results also suggest that the biotechnology regime changed and the Nobel Prize lost its luster as a signal of …
Persistent link: https://www.econbiz.de/10012749932
, such as intellectual human capital, can predict where and when biotechnology enterprises emerge and agglomerate. Density … more conjectural than empirically tenable. We argue and demonstrate for biotechnology that an alternative model based on … essentially uncorrelated with the panel data on biotechnology entry by year and region while the combined model has correlation …
Persistent link: https://www.econbiz.de/10013219977
.S. biotechnology enterprises during 1976-1989. Using a linked cross-section/time- series panel data set, we find that the timing and … structures. We believe biotechnology may be prototypical of the birth patterns in other innovative industries …
Persistent link: https://www.econbiz.de/10013238946
Although the official statistics imply that the rate of growth of real GDP in the United States has declined in recent years, it has still been substantially higher than the real growth rates in Europe and the other industrial countries, leading to higher real per capita incomes. This paper...
Persistent link: https://www.econbiz.de/10012960796
The United States emerged from World War II as the acknowledged global leader in basic science and its industrial application. While U.S. science has been able to maintain that preeminence in most areas, the nation's technological lead has met increasingly formidable challenges from abroad....
Persistent link: https://www.econbiz.de/10013227895
The expansion of U.S. universities after World War II gained from the arrival of immigrant scientists and graduate students, the broadening of access to universities, and the development of military research and high technology industry. Since the 1980s, however, growth of scientific research in...
Persistent link: https://www.econbiz.de/10013095711
In this paper, we examine the determinants of control rights in technology strategic alliances between biotechnology … firms and pharmaceutical corporations, as well as with other biotechnology firms. We undertake three clinical studies and an …
Persistent link: https://www.econbiz.de/10013224324
Using data on over 900 firms for the period 1988-2000, we estimate the effect on phase-specific biotech and pharmaceutical R&D success rates of a firm's overall experience, its experience in the relevant therapeutic category; the diversification of its experience, and alliances with large and...
Persistent link: https://www.econbiz.de/10013233843
Commercializing knowledge involves transfer from discovering scientists to those who will develop it commercially. New codes and formulae describing discoveries develop slowly - with little incentive if value is low and many competing opportunities if high. Hence new knowledge remains naturally...
Persistent link: https://www.econbiz.de/10013237924
We evaluate the effects of state-provided financial incentives for biotech companies, which are part of a growing trend of placed-based policies designed to spur innovation clusters. We estimate that the adoption of subsidies for biotech employers by a state raises the number of star biotech...
Persistent link: https://www.econbiz.de/10013035236